A recent report found that federal cannabis legalization could harm existing state markets where the plant is legal medically, recreationally, or both.
The Parabola Center for Law and Policy published a report that claimed federal cannabis legalization was bound to happen eventually, prohibition on the matter can only last for so long. It also mentioned that reforming cannabis would align positively with federal and state policies but could also harm or “disrupt and force the transformation of existing intrastate cannabis markets,” (1).
“How the nation will shift from dozens of individual state cannabis markets to one national market, and the implications of that shift, is unknown but likely to be dramatic,” the report stated (1). “It is also safe to assume that many advocates for federal de-scheduling are not aware of the consequences such a policy change portends for existing and entrenched state cannabis policies.”
To prevent the collapse of state markets throughout the US, Parabola is offering three key recommendations, as well as draft text to help fix the problem.
As their first recommendation, the Parabola Center for Law and Policy mentioned that federal legalization must include the preservation of states’ rights to prevent any disruption. They added that congress needs to “specifically state that it does not intend to preempt, prohibit, or otherwise limit any state law, regulation, or requirement regardless of whether the state law affects interstate commerce or favors in state interests,” (1).
The second recommendation was to prioritize small, social equity, and worker-owned cannabis businesses in interstate cannabis commerce where they are regulated via a registration system overseen by the federal government (1). Marijuana Moment mentioned that (1), “registrations should be additionally be reserved for state-licensed entities that are 1) involved in promoting industry diversity, 2) offering support and services to ‘disadvantaged individuals, veterans, or individuals and communities most affected by cannabis prohibition and enforcement’ or 3) protect workers’ rights to organize and co-own businesses.”
Lastly, for the third recommendation, it was proposed that “legalization should be coupled with provisions to minimize the potential for corporate consolidation and monopolization of the cannabis industry,” (1). This has been a problem the organization has mentioned in a previous educational campaign.
The Parabola Center for Law and Policy feels strongly that if cannabis industries continue only intrastate, state regulatory bodies potentially could become susceptible to liability under federal legalization (1). In the report, they mention there could be serious consequences for state-licensed companies throughout the US.
“If federal legalization is not coupled with explicit federal protections for state-based intra-state markets, everything will change once cannabis is de-scheduled. The world of legal cannabis will look nothing like it does now,” the center mentioned in the report (1). “But this outcome is not inevitable. Congress can protect intrastate markets if it chooses to.”
“Without protection for small businesses, a shift from fragmented intrastate markets to one large intrastate market through the end of federal prohibition and the demise of interstate barriers will likely lead to consolidation of the cannabis industry and a monopolization of the market by large cannabis companies. Additionally, large corporations currently operating in other areas will enter the cannabis market once the risks and constraints of federal prohibition are removed,” they stated (1).
“Whatever one thinks of the benefits of a consolidated interstate cannabis market, it is clear that such a market is unlikely to prioritize the social equity goals that have driven many states’ existing policies,” the report said (1). “Without specific efforts by Congress to protect state-level cannabis equity programs, and to limit market consolidation and monopolization, state efforts to create an equitable and inclusive industry will be wiped out.”
States such as, Oregon, Washington State, and California, have imposed laws which will create the infrastructure so that their states will be able to take part in cannabis imports and exports among legal states once there is federal legalization.
Reference
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.